Case number 2:18-cv-04195
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. KVK-TECH, INC. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 2 | Disclosure Statement Form 7.1 (1) |
| Jul 9, 2020 | 1 | Complaint (22) |
| Feb 5, 2019 | 8 | Stipulation of Dismissal (1) Docket Text: STIPULATION of Dismissal without Prejudice by DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC. (ETISH, SCOTT) |
| Feb 5, 2019 | 9 | Order (1) Docket Text: ORDER UPON CONSIDERATION OF THE PARTIES' STIPULATION OF DISMISSAL (DOC. NO. [8]), IT IS HEREBY ORDERED AS FOLLOWS: 1. THE STIPULATION OF DISMISSAL (DOC. NO. [8]) IS APPROVED AND ADOPTED; 2. PLAINTIFFS' COMPLAINT (DOC. NO. [1]) IS DISMISSED WITHOUT PREJUDICE. SEE FED. R. CIV. P. 41(A)(1)(B); AND 3. THE CLERK OF COURT SHALL CLOSE THIS CASE.SIGNED BY HONORABLE PAUL S. DIAMOND ON 2/5/2019. (COPY MAILED TO KVK-TECH, INC.) 2/5/2019 ENTERED AND COPIES E-MAILED.(rt) |
| Jan 29, 2019 | 7 | Notice (Other) (1) Docket Text: LETTER FROM RICHARD C. THIEME, DEPUTY CLERK TO HONORABLE PAUL S. DIAMOND TO SCOTT J. ETISH, ESQ. DATED 1/29/2019. (COPY MAILED TO KVK-TECH, INC.)(rt) |
| Jan 3, 2019 | 6 | Response to Order to Show Cause (2) Docket Text: Letter to Judge Diamond dated 1/3/2019 by VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC. (ETISH, SCOTT) Modified on 1/4/2019 (tjd). |
| Jan 2, 2019 | 5 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by KVK-TECH, INC.. KVK-TECH, INC. waiver sent on 11/28/2018, answer due 1/28/2019. (ETISH, SCOTT) |
| Dec 28, 2018 | 4 | Order to Show Cause (1) Docket Text: ORDER THAT PLFF SHALL SHOW CAUSE WHY THIS MATTER SHOULD NOT BE DISMISSED WITHOUT PREJUDICE FOR FAILURE TO PROSECUTE NO LATER THAN 1/11/2019. SIGNED BY HONORABLE PAUL S. DIAMOND ON 12/28/18. 12/28/18 ENTERED AND COPIES E-MAILED AND MAILED TO UNREPRESENTED PARTY.(kw, ) |
| Oct 2, 2018 | 3 | Order (8) Docket Text: STANDING ORDER OUTLINED HEREIN.SIGNED BY HONORABLE PAUL S. DIAMOND ON 10/2/2018. 10/2/2018 ENTERED AND COPIES E-MAILED.(rt) |
| Sep 27, 2018 | N/A | Summons Issued (0) Docket Text: 1 Summons Issued as to KVK-TECH, INC.. Forwarded To: PLAINTIFF'S COUNSEL on 9/28/2018 (amas) |
| Sep 27, 2018 | 1 | Exhibit A (15) |
| Sep 27, 2018 | 1 | Exhibit B (16) |
| Sep 27, 2018 | 1 | Exhibit C (17) |
| Sep 27, 2018 | 1 | Exhibit D (17) |
| Sep 27, 2018 | 1 | Exhibit E (11) |
| Sep 27, 2018 | 1 | Exhibit F (14) |
| Sep 27, 2018 | 1 | Exhibit G (17) |
| Sep 27, 2018 | 1 | Exhibit H (11) |
| Sep 27, 2018 | 1 | Civil Cover Sheet (1) |
| Sep 27, 2018 | 1 | Designation Form (1) |
| Sep 27, 2018 | 1 | Case Management Track Form (2) |
| Sep 27, 2018 | 2 | DISCLOSURE (1) |
| Sep 27, 2018 | 1 | Main Document (22) Docket Text: COMPLAINT against KVK-TECH, INC. ( Filing fee $ 400 receipt number 185402.), filed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMACEUTICALS IRELAND LTD., KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Civil Cover Sheet, # (10) Designation Form, # (11) Case Management Track Form)(amas) |
| Sep 27, 2018 | 2 | Main Document (1) Docket Text: Disclosure Statement Form pursuant to FRCP 7.1 Identifying Corporate Parent BAUSCH HEALTH COMPANIES, INC. for DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC. by DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC. (Attachments: # (1) DISCLOSURE)(amas) |
